Paper41544
Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients.
Heffron WA and 1 other. Br J Clin Pharmacol, 1979. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients. Papers, record 41544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41544
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Sleep Initiation and Maintenance Disorders | Major topic |
| Temazepam | Major topic |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Placebos | |
| Sleep | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,756,263 | A pilot, parallel-group, blinded, placebo-controlled, randomiseD, pRagmatic clinical trial investigating the Effect of temazepAM on objective and subjective measures of sleep in critically ill patients (the DREAM trial). | Crit Care Resusc | 2026 | https://conductscience.org/library/papers/41756263 | PubMed |
| 27,998,379 | Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. | J Clin Sleep Med | 2017 | https://conductscience.org/library/papers/27998379 | PubMed |
| 10,674,059 | Meta-analysis of benzodiazepine use in the treatment of insomnia. | CMAJ | 2000 | https://conductscience.org/library/papers/10674059 | PubMed |
| 6,146,327 | Temazepam's efficacy in patients with sleep onset insomnia. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6146327 | PubMed |
| 6,146,153 | Psycho-social stress, insomnia and temazepam: a sleep laboratory evaluation in a "general practice" sample. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6146153 | PubMed |
| 6,133,538 | The use of short- and long-acting hypnotics in clinical medicine. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6133538 | PubMed |
| 6,112,127 | Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic. | Drugs | 1981 | https://conductscience.org/library/papers/6112127 | PubMed |
| 2,891,534 | Pharmacokinetics of temazepam after day-time and night-time oral administration. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/2891534 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41544
GET https://conductscience.org/api/papers/v1/41544/authors